JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002472200 on April 20, 2000

J. Biol. Chem., Vol. 275, Issue 25, 19401-19408, June 23, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/25/19401    most recent
M002472200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, E. S.
Right arrow Articles by Chandraratna, R. A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, E. S.
Right arrow Articles by Chandraratna, R. A. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Recruitment of Nuclear Receptor Corepressor and Coactivator to the Retinoic Acid Receptor by Retinoid Ligands
INFLUENCE OF DNA-HETERODIMER INTERACTIONS*

Elliott S. KleinDagger §, Jenny W. WangDagger , Berket KhalifaDagger , Stacey A. GaviganDagger , and Roshantha A. S. ChandraratnaDagger §

From Retinoid Research, Departments of Dagger  Biology and  Chemistry, Allergan Pharmaceuticals, Irvine, California 92715

Ligand activation of retinoic acid receptors (RARs) involves coordinated changes in their interaction with coregulatory molecules. Binding of the agonist all-trans-retinoic acid to the RAR results in increased interaction with coactivator molecules as well as a decreased interaction with corepressor molecules. Thus, an all-trans-retinoic acid antagonist might function either by preventing agonist induction of such events or, additionally, by actively increasing repression via corepressor recruitment. We demonstrate that the repression of the transcriptional activity of a constitutively active RARgamma -VP-16 chimeric receptor by the inverse agonist AGN193109 requires a functional Co-R box and that binding of this ligand to RARgamma leads to an increased interaction with the corepressor N-CoR both in glutathione S-transferase pull-down and yeast two-hybrid analyses. Detection of nuclear receptor corepressor (N-CoR) association with RARgamma was greatly facilitated by inclusion of a RARE oligonucleotide in coimmunoprecipitation analyses, a result of an increase in association of the ternary complex consisting of RAR, RXR, and DNA. Similarly, this DNA-dependent increase in heterodimer formation likewise resulted in an increase in agonist-mediated recruitment efficiency of the coactivator SRC-1. Under conditions which favor ternary complex formation, a RAR neutral antagonist is distinguished from an inverse agonist with respect to corepressor recruitment as is a RAR partial agonist distinguished from an agonist with respect to coactivator recruitment. These results indicate that it is possible to design RAR ligands with distinct recruitment capabilities for coregulators, both coactivators as well as corepressors. In addition, using this recruitment assay, we show that SRC-1 and the related coactivator molecule ACTR associate with the ternary complex via utilization of different helical motifs within their conserved receptor interaction domains.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Mail code RD-3D, 2525 Dupont Dr., Irvine, CA 92715-9534. Tel.: 714-246-4895; Fax: 714-246-6207; E-mail: klein_elliott@allergan.com.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer
International Union of Pharmacology. LX. Retinoic Acid Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 712 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhao, S. Qin, L. I. Atangan, Y. Molina, Y. Okawa, H. T. Arpawong, C. Ghosn, J.-H. Xiao, V. Vuligonda, G. Brown, et al.
Casein Kinase 1{alpha} Interacts with Retinoid X Receptor and Interferes with Agonist-induced Apoptosis
J. Biol. Chem., July 16, 2004; 279(29): 30844 - 30849.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Dussault, M. Lin, K. Hollister, M. Fan, J. Termini, M. A. Sherman, and B. M. Forman
A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity
Mol. Cell. Biol., August 1, 2002; 22(15): 5270 - 5280.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. M. Scicchitano, L. Spath, A. Musaro, M. Molinaro, S. Adamo, and C. Nervi
AVP Induces Myogenesis through the Transcriptional Activation of the Myocyte Enhancer Factor 2
Mol. Endocrinol., June 1, 2002; 16(6): 1407 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. M. Harris, P. Lau, S. L. Chen, and G. E. O. Muscat
Characterization of the Retinoid Orphan-Related Receptor-{alpha} Coactivator Binding Interface: A Structural Basis for Ligand-Independent Transcription
Mol. Endocrinol., May 1, 2002; 16(5): 998 - 1012.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. M. Klinge, S. C. Jernigan, and K. E. Risinger
The Agonist Activity of Tamoxifen Is Inhibited by the Short Heterodimer Partner Orphan Nuclear Receptor in Human Endometrial Cancer Cells
Endocrinology, March 1, 2002; 143(3): 853 - 867.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T. Koide, M. Downes, R. A.S. Chandraratna, B. Blumberg, and K. Umesono
Active repression of RAR signaling is required for head formation
Genes & Dev., August 15, 2001; 15(16): 2111 - 2121.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K Niederreither, J Vermot, N Messaddeq, B Schuhbaur, P Chambon, and P Dolle
Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse
Development, January 4, 2001; 128(7): 1019 - 1031.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. I. Gonzalez and D. M. Robins
Oct-1 Preferentially Interacts with Androgen Receptor in a DNA-dependent Manner That Facilitates Recruitment of SRC-1
J. Biol. Chem., February 23, 2001; 276(9): 6420 - 6428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.